{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:49:18Z","timestamp":1790675358853,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["211182\/Z\/18\/Z"],"award-info":[{"award-number":["211182\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["project 430"],"award-info":[{"award-number":["project 430"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Antihypertensives are associated with increased risk of syncope, hypotension, and fractures, but the highest-risk individuals are unclear. This study aimed to develop and validate three models to predict these outcomes in patients with an indication for antihypertensive treatment. A cohort study was conducted using data from Clinical Practice Research Datalink (CPRD). Patients aged 40+ with systolic blood pressure 130-179\u2009mmHg were included. Outcomes were first hypotension, syncope, or fracture leading to hospitalization or death within 10 years. Models were derived from CPRD GOLD data (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20091,773,224) and validated with CPRD Aurum data (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20093,805,366). Each model had 31-37 predictors. Validation demonstrated strong discriminative ability (10-year C-statistic: hypotension 0.824; syncope 0.819; fracture 0.790), with close agreement between predicted and observed risks for the hypotension and syncope models. Some underprediction was observed for the fracture model. These models could be used to help reassure patients about the relatively low risk of harm from antihypertensive treatment, or identify the small number of individuals with a higher risk where additional monitoring may be indicated.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-64408-9","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T09:13:15Z","timestamp":1761210795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predicting hypotension, syncope, and fracture risk in patients indicated for antihypertensive treatment: the STRATIFY models"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9821-7608","authenticated-orcid":false,"given":"Constantinos","family":"Koshiaris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5360-9993","authenticated-orcid":false,"given":"Ariel","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kym IE","family":"Snell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9258-4060","authenticated-orcid":false,"given":"Richard J.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8741-3411","authenticated-orcid":false,"given":"Amitava","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhashisa","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7526-3038","authenticated-orcid":false,"given":"Christopher E.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5842-4645","authenticated-orcid":false,"given":"Rupert A.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7976-7172","authenticated-orcid":false,"given":"FD Richard","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ogden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3638-028X","authenticated-orcid":false,"given":"Richard J.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-8756","authenticated-orcid":false,"given":"James P.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the STRATIFY investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet A.","family":"Usher-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"64408_CR1","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington, S., Clarke, R., Qizilbash, N., Peto, R. & Collins, R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903\u20131913 (2002).","journal-title":"Lancet"},{"key":"64408_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","volume":"398","author":"K Rahimi","year":"2021","unstructured":"Rahimi, K. et al. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. Lancet 398, 1053\u20131064 (2021).","journal-title":"Lancet"},{"key":"64408_CR3","doi-asserted-by":"publisher","first-page":"n189","DOI":"10.1136\/bmj.n189","volume":"372","author":"A Albasri","year":"2021","unstructured":"Albasri, A. et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ 372, n189 (2021).","journal-title":"BMJ"},{"key":"64408_CR4","doi-asserted-by":"publisher","first-page":"e1004223","DOI":"10.1371\/journal.pmed.1004223","volume":"20","author":"JP Sheppard","year":"2023","unstructured":"Sheppard, J. P. et al. The association between antihypertensive treatment and serious adverse events by age and frailty: a cohort study. PLoS Med 20, e1004223 (2023).","journal-title":"PLoS Med"},{"key":"64408_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11906-022-01215-3","volume":"24","author":"JP Sheppard","year":"2022","unstructured":"Sheppard, J. P., Benetos, A. & McManus, R. J. Antihypertensive deprescribing in older adults: a practical guide. Curr. Hypertens. Rep. 24, 571\u2013580 (2022).","journal-title":"Curr. Hypertens. Rep."},{"key":"64408_CR6","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1001\/jama.2020.4871","volume":"323","author":"JP Sheppard","year":"2020","unstructured":"Sheppard, J. P. et al. Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients with hypertension aged 80 years and older: the OPTIMISE randomized clinical trial. JAMA 323, 2039\u20132051 (2020).","journal-title":"JAMA"},{"key":"64408_CR7","doi-asserted-by":"publisher","first-page":"e070918","DOI":"10.1136\/bmj-2022-070918","volume":"379","author":"L Archer","year":"2022","unstructured":"Archer, L. et al. Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study. BMJ 379, e070918 (2022).","journal-title":"BMJ"},{"key":"64408_CR8","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.3399\/BJGP.2022.0389","volume":"73","author":"C Koshiaris","year":"2023","unstructured":"Koshiaris, C. et al. Predicting the risk of acute kidney injury in primary care: derivation and validation of STRATIFY-AKI. Br. J. Gen. Pract. 73, e605 (2023).","journal-title":"Br. J. Gen. Pract."},{"key":"64408_CR9","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","volume":"336","author":"J Hippisley-Cox","year":"2008","unstructured":"Hippisley-Cox, J. et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 336, 1475\u20131482 (2008).","journal-title":"BMJ"},{"key":"64408_CR10","unstructured":"Overview | Hypertension in adults: diagnosis and management | Guidance | NICE. https:\/\/www.nice.org.uk\/guidance\/ng136 (2023)."},{"key":"64408_CR11","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1016\/S2666-7568(21)00088-X","volume":"2","author":"S Livingstone","year":"2021","unstructured":"Livingstone, S. et al. Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study. Lancet Healthy Longev. 2, e352\u2013e361 (2021).","journal-title":"Lancet Healthy Longev."},{"key":"64408_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jocd.2017.06.013","volume":"20","author":"JA Kanis","year":"2017","unstructured":"Kanis, J. A. et al. Overview of fracture prediction tools. J. Clin. Densitom. 20, 444\u2013450 (2017).","journal-title":"J. Clin. Densitom."},{"key":"64408_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis, J. A., Johnell, O., Oden, A., Johansson, H. & McCloskey, E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos. Int 19, 385\u2013397 (2008).","journal-title":"Osteoporos. Int"},{"key":"64408_CR14","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00198-008-0588-0","volume":"19","author":"ND Nguyen","year":"2008","unstructured":"Nguyen, N. D., Frost, S. A., Center, J. R., Eisman, J. A. & Nguyen, T. V. Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos. Int 19, 1431\u20131444 (2008).","journal-title":"Osteoporos. Int"},{"key":"64408_CR15","doi-asserted-by":"publisher","first-page":"e3427","DOI":"10.1136\/bmj.e3427","volume":"344","author":"J Hippisley-Cox","year":"2012","unstructured":"Hippisley-Cox, J. & Coupland, C. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ 344, e3427 (2012).","journal-title":"BMJ"},{"key":"64408_CR16","doi-asserted-by":"publisher","first-page":"e000316","DOI":"10.1136\/bmjmed-2022-000316","volume":"1","author":"SJ Livingstone","year":"2022","unstructured":"Livingstone, S. J. et al. Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population. BMJ Med. 1, e000316 (2022).","journal-title":"BMJ Med."},{"key":"64408_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03379-3","volume":"24","author":"JH Yoon","year":"2020","unstructured":"Yoon, J. H. et al. Prediction of hypotension events with physiologic vital sign signatures in the intensive care unit. Crit. Care 24, 1\u20139 (2020).","journal-title":"Crit. Care"},{"key":"64408_CR18","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1136\/hrt.2008.143123","volume":"94","author":"A Del Rosso","year":"2008","unstructured":"Del Rosso, A. et al. Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart 94, 1620\u20131626 (2008).","journal-title":"Heart"},{"key":"64408_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0196-0644(03)00823-0","volume":"43","author":"JV Quinn","year":"2004","unstructured":"Quinn, J. V. et al. Derivation of the San Francisco Syncope Rule to Predict Patients with Short-Term Serious Outcomes. Ann. Emerg. Med 43, 224\u2013232 (2004).","journal-title":"Ann. Emerg. Med"},{"key":"64408_CR20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jacc.2009.09.049","volume":"55","author":"MJ Reed","year":"2010","unstructured":"Reed, M. J. et al. The ROSE (risk stratification of syncope in the emergency department) study. J. Am. Coll. Cardiol. 55, 713\u2013721 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"64408_CR21","doi-asserted-by":"publisher","first-page":"e020740","DOI":"10.1136\/bmjopen-2017-020740","volume":"8","author":"CE Clark","year":"2018","unstructured":"Clark, C. E. et al. Detecting risk of postural hypotension (DROP): derivation and validation of a prediction score for primary care. BMJ Open 8, e020740 (2018).","journal-title":"BMJ Open"},{"key":"64408_CR22","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia, G. et al. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society Of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J. Hypertens. 41, 1874\u20132071 (2023).","journal-title":"J. Hypertens."},{"key":"64408_CR23","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1001\/2013.jamainternmed.469","volume":"172","author":"DA Butt","year":"2012","unstructured":"Butt, D. A. et al. The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch. Intern Med 172, 1739\u20131744 (2012).","journal-title":"Arch. Intern Med"},{"key":"64408_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12877-015-0154-5","volume":"15","author":"S Ruths","year":"2015","unstructured":"Ruths, S. et al. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study. BMC Geriatr. 15, 153 (2015).","journal-title":"BMC Geriatr."},{"key":"64408_CR25","doi-asserted-by":"publisher","first-page":"i3140","DOI":"10.1136\/bmj.i3140","volume":"353","author":"RD Riley","year":"2016","unstructured":"Riley, R. D. et al. External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges. BMJ 353, i3140 (2016).","journal-title":"BMJ"},{"key":"64408_CR26","doi-asserted-by":"publisher","first-page":"f2350","DOI":"10.1136\/bmj.f2350","volume":"346","author":"E Herrett","year":"2013","unstructured":"Herrett, E. et al. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ 346, f2350 (2013).","journal-title":"BMJ"},{"key":"64408_CR27","doi-asserted-by":"publisher","unstructured":"Wang, A. et al. Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendations. J. Hypertens. https:\/\/doi.org\/10.1097\/HJH.0000000000004032 (2025).","DOI":"10.1097\/HJH.0000000000004032"},{"key":"64408_CR28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett, E. et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J. Epidemiol. 44, 827\u2013836 (2015).","journal-title":"Int J. Epidemiol."},{"key":"64408_CR29","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyz034","volume":"48","author":"A Wolf","year":"2019","unstructured":"Wolf, A. et al. Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum. Int J. Epidemiol. 48, 1740\u20131740g (2019).","journal-title":"Int J. Epidemiol."},{"key":"64408_CR30","first-page":"E13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton, P. K. et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71, E13\u2013E115 (2018).","journal-title":"Hypertension"},{"key":"64408_CR31","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","volume":"38","author":"RD Riley","year":"2019","unstructured":"Riley, R. D. et al. Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes. Stat. Med 38, 1276\u20131296 (2019).","journal-title":"Stat. Med"},{"key":"64408_CR32","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/sim.9275","volume":"41","author":"RD Riley","year":"2022","unstructured":"Riley, R. D. et al. Minimum sample size calculations for external validation of a clinical prediction model with a time-to-event outcome. Stat. Med 41, 1280\u20131295 (2022).","journal-title":"Stat. Med"},{"key":"64408_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","volume":"13","author":"GS Collins","year":"2015","unstructured":"Collins, G. S., Reitsma, J. B., Altman, D. G. & Moons, K. G. M. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD Statement. BMC Med 13, 1\u201310 (2015).","journal-title":"BMC Med"},{"key":"64408_CR34","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine, J. P. & Gray, R. J. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94, 496 (1999).","journal-title":"J. Am. Stat. Assoc."},{"key":"64408_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41512-018-0035-4","volume":"2","author":"BG Feakins","year":"2018","unstructured":"Feakins, B. G., McFadden, E. C., Farmer, A. J. & Stevens, R. J. Standard and competing risk analysis of the effect of albuminuria on cardiovascular and cancer mortality in patients with type 2 diabetes mellitus. Diagn. Progn. Res 2, 1\u20139 (2018).","journal-title":"Diagn. Progn. Res"},{"key":"64408_CR36","first-page":"1","volume":"12","author":"ES Kawaguchi","year":"2019","unstructured":"Kawaguchi, E. S., Shen, J. I., Li, G. & Suchard, M. A. A fast and scalable implementation method for competing risks data with the R package fastcmprsk. R. J. 12, 1\u201318 (2019).","journal-title":"R. J."},{"key":"64408_CR37","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/ije\/28.5.964","volume":"28","author":"P Royston","year":"1999","unstructured":"Royston, P., Ambler, G. & Sauerbrei, W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J. Epidemiol. 28, 964\u2013974 (1999).","journal-title":"Int J. Epidemiol."},{"key":"64408_CR38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","volume":"69","author":"D Schoenfeld","year":"1982","unstructured":"Schoenfeld, D. Partial residuals for the proportional hazards regression model. Biometrika 69, 239 (1982).","journal-title":"Biometrika"},{"key":"64408_CR39","first-page":"141","volume":"5","author":"OO Aalen","year":"1978","unstructured":"Aalen, O. O. & Johansen, S. An empirical transition matrix for non-homogeneous markov chains based on censored observations. Scand. J. Stat. 5, 141\u2013150 (1978).","journal-title":"Scand. J. Stat."},{"key":"64408_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10985-008-9107-z","volume":"15","author":"F Graw","year":"2009","unstructured":"Graw, F., Gerds, T. A. & Schumacher, M. On pseudo-values for regression analysis in competing risks models. Lifetime Data Anal. 15, 241\u2013255 (2009).","journal-title":"Lifetime Data Anal."},{"key":"64408_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/0962280209105020","volume":"19","author":"PK Andersen","year":"2010","unstructured":"Andersen, P. K. & Pohar Perme, M. Pseudo-observations in survival analysis. Stat. Methods Med Res 19, 71\u201399 (2010).","journal-title":"Stat. Methods Med Res"},{"key":"64408_CR42","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1177\/1536867X1401400403","volume":"14","author":"P Royston","year":"2014","unstructured":"Royston, P. Tools for checking calibration of a Cox model in external validation: Approach based on individual event probabilities. Stata J. 14, 738\u2013755 (2014).","journal-title":"Stata J."},{"key":"64408_CR43","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin, P. C. & Fine, J. P. Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat. Med 36, 4391\u20134400 (2017).","journal-title":"Stat. Med"},{"key":"64408_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-017-0336-2","volume":"17","author":"MS Rahman","year":"2017","unstructured":"Rahman, M. S., Ambler, G., Choodari-Oskooei, B. & Omar, R. Z. Review and evaluation of performance measures for survival prediction models in external validation settings. BMC Med Res Methodol. 17, 1\u201315 (2017).","journal-title":"BMC Med Res Methodol."},{"key":"64408_CR45","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1177\/0962280217705678","volume":"27","author":"KIE Snell","year":"2018","unstructured":"Snell, K. I. E., Ensor, J., Debray, T. P. A., Moons, K. G. M. & Riley, R. D. Meta-analysis of prediction model performance across multiple studies: which scale helps ensure between-study normality for the C-statistic and calibration measures? Stat. Methods Med Res 27, 3505\u20133522 (2018).","journal-title":"Stat. Methods Med Res"},{"key":"64408_CR46","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1177\/0962280218785504","volume":"28","author":"TPA Debray","year":"2019","unstructured":"Debray, T. P. A. et al. A framework for meta-analysis of prediction model studies with binary and time-to-event outcomes. Stat. Methods Med Res 28, 2768\u20132786 (2019).","journal-title":"Stat. Methods Med Res"},{"key":"64408_CR47","doi-asserted-by":"publisher","first-page":"i6","DOI":"10.1136\/bmj.i6","volume":"352","author":"AJ Vickers","year":"2016","unstructured":"Vickers, A. J., Van Calster, B. & Steyerberg, E. W. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ 352, i6 (2016).","journal-title":"BMJ"},{"key":"64408_CR48","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/sim.3618","volume":"28","author":"IR White","year":"2009","unstructured":"White, I. R. & Royston, P. Imputing missing covariate values for the Cox model. Stat. Med 28, 1982 (2009).","journal-title":"Stat. Med"},{"key":"64408_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40471-018-0142-3","volume":"5","author":"B Lau","year":"2018","unstructured":"Lau, B. & Lesko, C. Missingness in the setting of competing risks: from missing values to missing potential outcomes. Curr. Epidemiol. Rep. 5, 153\u2013159 (2018).","journal-title":"Curr. Epidemiol. Rep."},{"key":"64408_CR50","doi-asserted-by":"publisher","unstructured":"Rubin, D. B. et al. Multiple Imputation for Nonresponse in Surveys. https:\/\/doi.org\/10.1002\/9780470316696 (1987).","DOI":"10.1002\/9780470316696"},{"key":"64408_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-9-57","volume":"9","author":"A Marshall","year":"2009","unstructured":"Marshall, A., Altman, D. G., Holder, R. L. & Royston, P. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol. 9, 1\u20138 (2009).","journal-title":"BMC Med Res Methodol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64408-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64408-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64408-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:02:45Z","timestamp":1761213765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64408-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64408"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64408-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have completed the ICMJE uniform disclosure form at (\n                      \n                      ) and declare: authors had financial support from the Wellcome Trust, Royal Society, and National Institute for Health Research for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9371"}}